Vimarsana
Biggest News Aggregation in the World

After Last News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from After Last. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In After Last Today - Breaking & Trending Today

Colombia's Critically Endangered Species Doubled Since 2017 - Vimarsana News

Colombia's Critically Endangered Species Doubled Since 2017

As Colombia prepares for the COP16 biodiversity conference, the government announced that the number of endangered species in the country has doubled. Read more here.

Still Have Rs 2,000 Notes After Last Date? 2 Steps To Get Money In The Bank - Vimarsana News

Still Have Rs 2,000 Notes After Last Date? 2 Steps To Get Money In The Bank

People can send their Rs 2,000 banknotes to specified regional offices of the Reserve Bank through the insured post for credit directly in their bank accounts.

Source: ndtv.com
The Best Halley's Comet Meteor Shower Has Begun—Here's When To See It - Vimarsana News

The Best Halley's Comet Meteor Shower Has Begun—Here's When To See It

The Orionid meteor shower runs from September 26 to November 22 in 2023, peaking on October 21, and is caused by Halley's comet.

Source: forbes.com
The Next Big Meteor Shower Could See A Huge 'Outburst,' Say Scientists - Vimarsana News

The Next Big Meteor Shower Could See A Huge 'Outburst,' Say Scientists

If the Perseids are the most popular meteor shower of the year, they’re not quite the most prolific. Here’s all you need to know about meteor showers coming up in 2023.

Source: forbes.com
Stoke Therapeutics Announces Positive New Safety & Efficacy Data from Patients Treated with STK-001 - Vimarsana News

Stoke Therapeutics Announces Positive New Safety & Efficacy Data from Patients Treated with STK-001

– Totality of data from these ongoing studies suggest clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modification –– Phase 1/2a ADMIRAL Study Data STK-001 (70mg): Patients treated with 2 or 3 ini...